Fortive Corporation research snapshot
FTV AI stock analysis currently reads Fortive Corporation as a high-margin industrial technology and healthcare workflow company with credible Fortive Business System execution, recurring service and software exposure, and strong free cash flow conversion. The main limits are valuation, modest organic growth, debt after the Ralliant separation, and the risk that share repurchases mask weaker demand. FTV closed at $62.55 on July 7, 2026, and the audited market cap check produced about $19.07 billion using 304,861,021 shares outstanding. This FTV AI stock forecast is scenario-based, not a price promise, and should be used as an information tool rather than investment advice.
Current price
$62.55
Market cap
$19.07 billion verified market cap
AI score
69 / 100
Rating
Quality industrial technology compounder with solid margins, strong cash conversion, and post spin-off comparability risk
Trend status
Constructive but extended near the 52-week high, with price above the 50-day and 200-day moving averages but below the 5-day average
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Fortive sells essential instrumentation, safety, productivity, facility software, sterilization, biomedical test, radiation safety, and clinical workflow products. The business is asset-light for an industrial name and produces strong margins. | Medium-high |
| Moat | Brand franchises, installed base, regulated workflows, service networks, workflow software, switching friction, and Fortive Business System discipline create a narrow to moderate moat. | Medium-high |
| Management | CEO Olumide Soroye is emphasizing Fortive Accelerated, organic growth, disciplined capital allocation, share repurchases, and investor trust. The test is whether post spin-off growth improves without overusing buybacks. | Medium |
| Financial trend | FY2025 continuing-operations revenue was $4.159 billion, net income was $533 million, adjusted EBITDA margin was 29.6%, and free cash flow was $931 million. Q1 2026 revenue grew 7.7% to $1.069 billion. | High |
| Valuation | At $62.55, audited math shows 37.23x trailing EPS, 3.14x book value, 20.51x FY2025 FCF per share, 4.59x sales, and a 0.38% dividend yield. The multiple needs sustained growth and cash conversion. | Medium-high |
| Technical trend | Daily technical data is constructive but not cleanly cheap. Investing.com showed RSI near 49.54, MACD near 0.26, MA5 near $62.76, MA50 near $61.89, MA200 near $60.90, and price close to the 52-week high. | Medium |
| Risk level | Key risks are industrial demand softness, hospital capital spending delays, integration or portfolio mistakes, cybersecurity events, leverage, valuation compression, and lower growth after Ralliant separation. | Medium-high |
| AI confidence | Descriptive data confidence is high because current company filings and third-party market data are available. Forecast confidence is medium because forward EPS depends on organic growth, margin durability, and capital allocation. | High data confidence |
| Investment certainty | FTV looks like a quality industrial technology name at a fair-to-full valuation, not a distressed value setup. The investment case needs evidence that organic growth and FCF conversion can justify the multiple. | Medium |
FTV AI stock forecast
The FTV AI stock forecast uses the $62.55 price reference, FY2026 adjusted EPS guidance midpoint of $2.95, and a three-year earnings multiple model. The audited model produced a bearish value near $41.60, a base value near $66.40, and a bullish value near $89.20 before dividends. These are scenario ranges, not guaranteed targets.
$84 to $92
More likely if core growth stays near or above mid-single digits, adjusted EBITDA margin expands, FCF conversion remains above 100% of adjusted net income, healthcare workflows recover, and the market pays near 24x forward earnings.
$62 to $70
More likely if adjusted EPS compounds near 4%, Fortive keeps margins near the 29% to 30% adjusted EBITDA range, repurchases continue at disciplined prices, and the market applies a near 20x multiple.
$39 to $45
More likely if industrial orders weaken, hospital capital spending slows, post spin-off cost structure disappoints, debt limits capital allocation, or investors compress FTV toward a mid-teens earnings multiple.
FTV AI technical analysis
FTV AI technical analysis uses market data available at the July 8, 2026 cutoff. FTV closed at $62.55 on July 7, 2026. Investing.com showed RSI near 49.54, MACD near 0.26, a 5-day moving average near $62.76, a 50-day moving average near $61.89, and a 200-day moving average near $60.90. Google Finance showed a 52-week high of $64.34 and a 52-week low of $46.34.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $62.55 | July 7, 2026 close from MarketWatch and Google Finance market data. |
| Near-term support | $61.89 to $60.90 | The 50-day and 200-day moving averages are the first trend support zone to monitor. |
| Secondary support | $59.50 to $60.00 | A round-number and prior consolidation area that matters if the moving-average zone fails. |
| Deeper support | $55.00 to $56.00 | A wider risk-control area tied to the prior trading range before the recent breakout. |
| Short moving average | $62.76 | The close was slightly below the 5-day moving average, so near-term momentum cooled after the 52-week high. |
| 50-day trend | $61.89 | A hold above this level keeps the short-to-intermediate trend constructive. |
| 200-day trend | $60.90 | A break below the 200-day average would weaken the larger trend repair thesis. |
| Resistance zone | $63.60 to $64.34 | FTV set a new 52-week high at $64.34 on July 6, 2026, making this the main breakout zone. |
| Momentum | RSI near 49.54, MACD near 0.26 | Momentum is positive on MACD but not overbought on RSI, so confirmation above resistance matters. |
| Volume | About 2.0 million versus 3.25 million average volume | MarketWatch and Google Finance showed volume below average on July 7, so a stronger breakout needs better volume. |
| Volatility | Industrial-cycle and earnings-sensitive | FTV can reprice around earnings, orders, healthcare capital spending, acquisition news, and portfolio actions. |
| Invalidation | Close below $60.90 | A decisive close below the 200-day average would reduce confidence in the current trend-following setup. |
FTV AI trading strategy
The FTV AI trading strategy below is a rules-based research framework, not personal advice. It connects price action with core revenue growth, adjusted EBITDA margin, free cash flow conversion, buyback discipline, healthcare workflow demand, leverage, and post spin-off execution.
Watch for FTV to clear the $63.60 to $64.34 resistance zone on above-average volume while holding the 50-day moving average near $61.89 and confirming that Q2 commentary supports the upper half of 2026 adjusted EPS guidance.
A close below the 200-day moving average near $60.90, a core growth slowdown, or weaker FCF conversion should reduce trend-following confidence.
If FTV pulls back toward $59.50 to $60.90 without deterioration in orders, margins, balance sheet liquidity, or healthcare demand, compare the entry price with the audited base and bear scenarios before acting.
Do not treat the stock as cheap only because it pulled back. At more than 20x FY2025 FCF per share, valuation still requires durable execution.
Track IOS and AHS sales, core revenue growth, adjusted EBITDA margin, FCF conversion, net debt, share repurchase price discipline, acquisition activity, and management commentary on Fortive Accelerated.
Position sizing should reflect that FTV is a quality cyclical industrial technology company, not a risk-free bond substitute or guaranteed compounder.
Investment research summary
Customers pay Fortive for mission-critical tools, software, safety systems, sterilization workflows, biomedical testing, radiation monitoring, and service support that improve uptime, compliance, productivity, and care delivery.
Fortive benefits from specialized brands, installed base, regulatory and workflow switching friction, service channels, software attachment, and operating discipline. The moat weakens if cheaper competitors match reliability or customers delay replacements.
The thesis fails if post spin-off Fortive grows too slowly, if buybacks happen at rich prices, if healthcare demand weakens, if debt constrains optionality, or if a cybersecurity or product quality issue damages trust.
Olumide Soroye is focusing on Fortive Accelerated, organic growth, margin discipline, repurchases, and investor credibility. The key capital allocation test is whether repurchases and acquisitions lift intrinsic value per share.
Fortive sits in long-running trends around industrial automation, connected worker safety, facility software, healthcare productivity, sterilization, and compliance. These are attractive trends, but they still cycle with industrial and hospital budgets.
At $62.55, FTV is not priced as a deep value stock. The base-case margin of safety depends on mid-single-digit EPS growth, strong FCF conversion, and a market multiple near 20x earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| FTV quote reference | $62.55 close on July 7, 2026 | MarketWatch FTV daily market data | July 8, 2026 |
| Market capitalization verification | $19.07 billion calculated from $62.55 x 304,861,021 shares outstanding | Pineify financial_rigor.py, Google Finance, and Fortive Q1 2026 10-Q | July 8, 2026 |
| Shares outstanding | 304,861,021 common shares outstanding at April 24, 2026 | Fortive Q1 2026 Form 10-Q | July 8, 2026 |
| FY2025 continuing-operations revenue and net income | $4.159 billion revenue and $533 million GAAP net income, cross-validated against Fortive FY2025 release and 2025 Form 10-K | Fortive FY2025 results release and 2025 Form 10-K | July 8, 2026 |
| Q1 2026 revenue and earnings | $1.069 billion revenue, $136 million GAAP net earnings, $314 million adjusted EBITDA, $194 million free cash flow, and $0.70 adjusted EPS | Fortive Q1 2026 results release | July 8, 2026 |
| Cash and debt | $356.1 million cash and equivalents from Q1 2026 10-Q, cross-checked with Yahoo key statistics; Yahoo listed total debt at $3.58 billion | Fortive Q1 2026 Form 10-Q and Yahoo Finance key statistics | July 8, 2026 |
| Valuation ratios | Audited math: 37.23x trailing EPS, 3.14x book value, 20.51x FY2025 FCF per share, 4.59x sales, and 0.38% dividend yield | Pineify financial_rigor.py using Google Finance and Fortive filing inputs | July 8, 2026 |
| Daily technical indicators | RSI 49.544, MACD 0.260, MA5 $62.76, MA50 $61.89, MA200 $60.90 | Investing.com FTV technical analysis | July 8, 2026 |
| 52-week range and market data | 52-week high $64.34, 52-week low $46.34, beta 1.05, market cap $19.07 billion, shares outstanding 304.86 million | Google Finance FTV quote page | July 8, 2026 |
This page is an informational research tool only and is not investment advice, a recommendation, or a promise of future performance. Forecast scenarios are based on available public data as of July 8, 2026, and may be wrong if Fortive growth, margins, capital allocation, leverage, healthcare demand, industrial demand, or market multiples change.
